Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Stay in Touch with Those Important People

Neil Wainwright, CEO of UpHabit, discusses the company’s app that helps users stay connected and strengthen relationships with important people in their lives. “I’m a serial entrepreneur, so I’ve had sev...

Biopharma Receives FDA Fast Track Designation for Cancer Therapeutic

An explanation of the categorization and its implications are provided in a Paradigm Capital report. In a May 30 research note, Paradigm Capital analyst Rahul Sarugaser reported that Zymeworks Inc.'s (ZYME:NYSE; ZYME:TSX) lead product candidate ZW25 wa...

Copper bulls ride on increased orders, mine disruptions

Hit hard by the pandemic when it first struck China in February, then again in March when it spread to the Middle East, Europe and North America, over the past month copper prices have ticked up, as economies gradually reopen and growth prospects improve. True to its “Dr. ...

Valeo Pharma Big Pharma Capabilities Presents Opportunity

Valeo Pharma Inc. is a Canadian specialty pharmaceutical company with big pharma capabilities while retaining small company flexibilities. Valeo is a fast-growing revenue generating company with a strong product portfolio and a robust product pipeline. Valeo Pharma In...

Bioasis Engages With the FDA: Here's What It Means

Last week Bioasis Technologies Inc. (BTI:TSX.V) heard back from the FDA on written questions they had submitted. These questions concern their lead investigational candidate xB3-001 and its development path. The company's goal, of course, is to bring this therapeutic in...

How Machine Learning Will Affect E-commerce Industry in near future

Machine learning and artificial intelligence have in one way or the other, immensely contributed to bringing e-commerce to a value of $2.3 trillion in the market. Machine learning brought a revolution in the said field by helping merchants better analyse their businesse...

Acceleron Shares Open 50% Higher on Phase 2 PAH Trial Data

Acceleron Pharma's shares established a new 52-week high after the company reported that sotatercept achieved both primary and secondary endpoints in the Phase 2 PULSAR study in patients with pulmonary arterial hypertension. After U.S. markets closed for trading ye...

Will Fed‘s Cap On Interest Rates Trigger Gold’s Rally?

Last week, the FOMC released the minutes from its last meeting. What implications do they carry for the gold market? FOMC Finally Acknowledges the Situation As Serious Last week, the FOMC has published minutes of its meeting from April 28-29. They show that the Fed...

A Unique Play in the Hungry US Hemp Market

(Image via Cascadia Extracts.) Utilizing high capacity CO 2 extraction equipment to tap into the extremely underserviced hemp market, Cascadia Extracts ( P. CASCADIA , Forum ) uses unique technology to take advantage of the significant benefits associated w...

When Will the ATOM Bomb Launch?

Investment advisor Daniel Carlson makes his case for why investors should have no fear of losing out on this technology company. Atomera Inc. (ATOM:NASDAQ) is going to blow up. I mean this in a good way, not in the implosion sort of manner. ATOM is a tickin...
1 2 3 4 5 6 7 8 9 10 ...